PMGC Holdings Inc. (ELAB) vs NEXGEL, Inc. (NXGL)
A side-by-side comparison of PMGC Holdings Inc. and NEXGEL, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ELAB
PMGC Holdings Inc.
$3.27HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT
NXGL
NEXGEL, Inc.
$0.17HealthcareDelayed quote: Oct 6, 2026, 12:52 PM EDT
Total return — ELAB vs NXGL
growth of $100 · dividends reinvested · last 3yELAB -100.0% (-99.4%/yr)NXGL -90.8% (-54.8%/yr)NXGL compounded faster over this window
Log scale — wide-divergence pair
ELAB NXGL
ELAB vs NXGL: by the numbers
- •ELAB is the larger company ($1M vs $1M market cap).
- •Both run net losses; NXGL's is the smaller (-51.26% vs -522.97% net margin).
Metrics side by side
Valuation
| Metric | ELAB | NXGL |
|---|---|---|
| P/S ratio | 0.58 | 0.12 |
| P/B ratio | 0.09 | 0.29 |
Profitability
| Metric | ELAB | NXGL |
|---|---|---|
| Gross margin | 10.31% | 35.07% |
| Operating margin | -1250.11% | -29.35% |
| Net margin | -522.97% | -51.26% |
| ROE | -80.57% | -124.97% |
| ROIC | N/A | -41.80% |
Growth (annualized)
| Metric | ELAB | NXGL |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 63.69% |
Go deeper
Dig into the metrics
PMGC ROENEXGEL ROEPMGC operating marginNEXGEL operating marginPMGC revenue growthNEXGEL revenue growthPMGC free cash flowNEXGEL free cash flow
PMGC & NEXGEL appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.